Librax (Chlordiazepoxide, Clidinium Bromide)

• Librax combines a benzodiazepine and an anticholinergic to manage gastrointestinal disorders.
• Peptic ulcer disease: reduces gastric acid secretion and relieves ulcer‑related pain.
• Gastro‑oesophageal reflux disease: alleviates reflux symptoms and promotes ulcer healing.
• Irritable bowel syndrome: decreases intestinal spasms and abdominal discomfort.
• Functional dyspepsia: improves dyspeptic symptoms by reducing gastric motility.

• Chlordiazepoxide potentiates the activity of the GABA‑A receptor, producing anxiolytic, sedative and muscle‑relaxant effects that lessen gastrointestinal smooth‑muscle tension. Clidinium bromide blocks muscarinic receptors in the gastrointestinal tract, decreasing secretions and motility, thereby complementing the antispasmodic action of the benzodiazepine component.

Librax may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Drowsiness: feeling unusually sleepy or fatigued.
• Dry mouth: reduced salivary flow leading to a parched sensation.
• Constipation: slowed intestinal transit causing hard stools.
• Blurred vision: temporary difficulty focusing.
• Dizziness: light‑headed sensation, especially on standing.
• Nausea: mild stomach upset.

Serious or Rare Side Effects

• Severe respiratory depression: markedly reduced breathing effort.
• Dependence or withdrawal: signs of addiction with abrupt discontinuation.
• Anaphylaxis: sudden, life‑threatening allergic reaction.
• Marked hypotension: significant drop in blood pressure.
• Confusion or delirium: altered mental status, especially in the elderly.
• Seizures: rare occurrence of convulsive episodes.

• Before prescribing Librax, clinicians should consider several safety measures.
• Assess for dependence: evaluate patient history of substance abuse.
• Monitor for sedation: advise patients not to operate machinery while drowsy.
• Caution in elderly: increased sensitivity to anticholinergic effects may cause falls.
• Avoid in acute narrow‑angle glaucoma: anticholinergic action can precipitate an attack.
• Pregnancy Category D: use only when benefits outweigh potential fetal risks.
• Store at ambient temperature: keep in the original pack, protect from moisture and light.

Librax interacts with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

• Alcohol: additive CNS depression leading to profound sedation.
• Opioids or other benzodiazepines: risk of respiratory depression and profound sedation.
• Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase plasma levels of both components.

Moderate Interactions (Monitor Closely)

• Anticholinergic agents (e.g., antihistamines): may enhance dry‑mouth and constipation.
• CYP3A4 inducers (e.g., rifampin): may reduce therapeutic effectiveness.
• Antihypertensives: potential additive hypotensive effect.